This section is specifically directed to physicians who have WM patients.
Waldenstrom’s macroglobulinemia (WM) is a rare and unique disease. Many oncologists may not have encountered patients with this type of blood cancer before. We hope you will read the information recommended to you in this section prior to deciding on a treatment protocol for your patients. If the IWMF can be of assistance to you in any other way, please let us know.
There is a tremendous amount of basic research into WM underway in both the US and abroad, resulting in new pharmaceutical protocols and rapidly changing therapeutic opportunities .
The remainder of this section will assist you in learning more about diagnosis, treatment, and prognosis of WM and guide you to additional professional resources.
Materials for Physicians
- Waldenstrom’s Macroglobulinemia - Review of Therapy, most recently updated in November 2008, is a technical booklet written by Dr. Morie Gertz of Mayo Clinic, an authority on the treatment of WM. It is available separately or as part of the physicians' Information Package.
- Physicians' Information Package (Info Pak) includes the above booklet plus the following sample of publications for patients and brochures for your office. Please click here to order your Info Pak online.
- You may want to subscribe to the physicians' WM Mailing List, which is maintained for medical professionals. Subscription ensures that you will receive the Torch – the IWMF quarterly newsletter – plus special bulletins, research results, updates on clinical trials, and other information of interest to professionals treating WM patients or engaged in WM-related medical research. The physicians' WM Mailing List is guaranteed spam-free and is never exchanged or given to others. Mailings are occasional, with the exception of the quarterly newsletter. To sign up, contact the IWMF Office.